Valor202020212022202320242025TTMGastos comerciales, generales y administrativos6.9 B8.2 B8.52 B7.33 B7.76 B8.23 B8.23 BInvestigación y desarrollo1.35 B1.74 B1.75 B1.5 B1.58 B1.6 B1.6 BBeneficio operativo4.23 B7.46 B8.69 B5.2 B4.86 B4.69 B4.69 BTotal de ingresos no operativos583 M881 M-456 M-54 M184 M-431 M-431 MGastos por intereses, netos de intereses capitalizados275 M238 M211 M286 M278 M265 M265 MIngresos no operativos, una vez deducidos los gastos por intereses269 M187 M-441 M-165 M-38 M-474 M-474 MIngresos/gastos extraordinarios39 M456 M-226 M-175 M-56 M-222 M-222 MBeneficio antes de impuestos4.5 B7.6 B8.29 B5.04 B4.65 B4.23 B4.23 BParticipación en los beneficios———————Impuestos849 M1.25 B1.08 B823 M747 M633 M633 MParticipación minoritaria———————Otros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas3.06 B5.84 B7.21 B4.22 B3.9 B3.6 B3.61 BOperaciones suspendidas589 M589 M0543 M014 M—Beneficio neto3.65 B6.43 B7.21 B4.76 B3.9 B3.61 B3.61 BAjuste por dilución1 M78 M20 M000—Dividendos de las acciones preferentes136 M164 M106 M21 M00—Beneficio neto diluido atribuible a los accionistas3.51 B6.35 B7.12 B4.74 B3.9 B3.61 B3.61 BBeneficio básico por acción4.978.779.86.445.335.075.07Beneficio por acción diluido4.898.619.666.385.295.055.05Número medio de acciones ordinarias706.2 M714.6 M725.1 M736.5 M731 M712.7 M2.86 BAcciones diluidas718.7 M736.8 M737.1 M743.1 M737.2 M716.1 M2.87 BEBITDA4.82 B8.14 B9.39 B5.76 B5.28 B4.84 B4.88 BEBIT3.04 B5.97 B7.17 B3.59 B2.93 B2.4 B1.16 BCosto de los ingresos9.81 B11.5 B12.52 B9.86 B9.67 B10.04 B10.04 BOtros costes de producción———————Amortización y depreciación (flujo de caja)1.77 B2.17 B2.22 B2.17 B2.35 B2.45 B3.72 B
Danaher Corporation
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.